Elanco Animal Health (ELAN) Net Margin (2017 - 2026)

Elanco Animal Health (ELAN) reported Net Margin of 4.16% for Q1 2026, down 146.0% on a YoY basis from 9.04% in Q1 2025, and up 117.23% sequentially from 24.13% in Q4 2025.

Elanco Animal Health (ELAN) Net Margin (2017 - 2026) Analysis & Trends

Elanco Animal Health (ELAN) has 10 years of Net Margin data on file, last reported at 4.16% in Q1 2026.

  • For the quarter ending Q1 2026, Net Margin fell 146.0% year-over-year to 4.16%; the trailing twelve-month figure through Mar 2026 stood at 4.95% (down 1337.0% YoY), and the FY2025 full-year result was 4.92%, down 1253.0% from the prior year.
  • Net Margin grew to 4.16% in Q1 2026, from 24.13% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 35.34% in Q3 2024 to a low of 102.62% in Q3 2023.
  • A 5-year average of 6.42% and a median of 0.85% in 2022 frame the typical range for Net Margin.
  • Across the five-year window, Net Margin slumped 9629 bps in 2023 and surged 13796 bps in 2024, its largest moves.
  • Tracing ELAN's Net Margin over 5 years: stood at 5.48% in 2022, then sank by 148 bps to 13.62% in 2023, then jumped by 94 bps to 0.78% in 2024, then slumped by 2976 bps to 24.13% in 2025, then jumped by 117 bps to 4.16% in 2026.
  • Business Quant data shows ELAN's Net Margin at 4.16% in Q1 2026, 24.13% in Q4 2025, and 2.99% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 9.29%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 26.57%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -33.66%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 35.18%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 5.03%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 24.30%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 4.16%
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn -21.19%

Historic Data

Download Data
DateValue
Mar 31, 2026 4.16%
Dec 31, 2025 -24.13%
Sep 30, 2025 -2.99%
Jun 30, 2025 0.89%
Mar 31, 2025 5.62%
Dec 31, 2024 -0.78%
Sep 30, 2024 35.34%
Jun 30, 2024 -4.22%
Mar 31, 2024 2.66%
Dec 31, 2023 -13.62%
Sep 30, 2023 -102.62%
Jun 30, 2023 -9.18%
Mar 31, 2023 8.19%
Dec 31, 2022 -5.48%
Sep 30, 2022 -6.34%
Jun 30, 2022 -0.85%
Mar 31, 2022 4.16%
Dec 31, 2021 -9.44%
Sep 30, 2021 -9.55%
Jun 30, 2021 -16.12%